NCT00137735View on ClinicalTrials.gov

Gabapentin for Carpal Tunnel Syndrome

PHASE3CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

October 31, 2003

Study Completion Date

December 31, 2006

Conditions
Carpal Tunnel Syndrome
Interventions
DRUG

Gabapentin

300mg tds

OTHER

placebo

tds

Trial Locations (2)

Unknown

Prince of Wales Hospital, Shatin, New Territories

North District Hospital, Sheung Shui, New Territories

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Chinese University of Hong Kong

OTHER

NCT00137735 - Gabapentin for Carpal Tunnel Syndrome | Biotech Hunter | Biotech Hunter